HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Fernando Santos-Simarro Selected Research
Fernando Santos-Simarro Research Topics
Disease
2
Neurodevelopmental Disorders
01/2022 - 01/2021
2
Language Development Disorders (Semantic-Pragmatic Disorder)
01/2021 - 12/2015
1
Retinal Dystrophies
04/2022
1
Myopia
04/2022
1
Achondroplasia
01/2022
1
Intellectual Disability (Idiocy)
01/2022
1
Cataract (Cataracts)
01/2021
1
Floating-harbor syndrome
01/2021
1
Necrosis
01/2020
1
Hypertrichosis
01/2019
1
Epilepsy (Aura)
01/2019
1
Polyuria
01/2019
1
Nephrogenic Diabetes Insipidus
01/2019
1
Gingival Overgrowth
01/2019
1
Channelopathies
01/2019
1
Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
01/2019
1
Blepharo-cheilo-dontic syndrome
01/2018
1
Marshall-Smith syndrome
01/2018
1
CLAPO Syndrome
01/2018
1
Craniosynostoses (Craniosynostosis)
11/2017
1
Persistent Fetal Circulation Syndrome
05/2016
1
Hereditary Nephritis (Alport Syndrome)
01/2012
Drug/Important Bio-Agent (IBA)
6
Proteins (Proteins, Gene)
FDA Link
01/2022 - 01/2012
2
DNA (Deoxyribonucleic Acid)
IBA
01/2021 - 01/2018
1
ethanoxyhexamercarbide
IBA
04/2022
1
Tyrosine Kinase Inhibitors
IBA
01/2022
1
infigratinib
IBA
01/2022
1
Glutamine (L-Glutamine)
FDA Link
01/2022
1
Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
IBA
01/2022
1
Monomeric GTP-Binding Proteins
IBA
01/2020
1
Mitogen-Activated Protein Kinases
IBA
01/2020
1
Potassium
IBA
01/2019
1
Arginine Vasopressin (Argipressin)
IBA
01/2019
1
Catenins
IBA
01/2018
1
Cadherins (E-Cadherin)
IBA
01/2018
1
Codon (Codons)
IBA
01/2018
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
11/2017
1
Long Noncoding RNA
IBA
05/2016
1
Ubiquitin
IBA
12/2015
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
12/2015
1
Glycine (Aminoacetic Acid)
FDA Link
Generic
01/2012
1
Valine (L-Valine)
FDA Link
01/2012
1
Collagen Type IV (Type IV Collagen)
IBA
01/2012
Therapy/Procedure
1
Therapeutics
01/2022